Fludarabine Phosphate (Sandoz Inc)
Welcome to the PulseAid listing for the Fludarabine Phosphate drug offered from Sandoz Inc. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | Fludarabine Phosphate |
| SUBSTANCE NAME: | FLUDARABINE PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2007-10-12 |
| END MARKETING DATE: | 0000-00-00 |
Fludarabine Phosphate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fludarabine Phosphate from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/mL) |
| START MARKETING DATE: | 2007-10-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66758-046_ff9d0403-be44-469d-9dfe-d2156094bf60 |
| PRODUCT NDC: | 66758-046 |
| APPLICATION NUMBER: | NDA022137 |
Other FLUDARABINE PHOSPHATE Pharmaceutical Manufacturers / Labelers:
